Generate Biomedicines, Inc. (GENB) KPIs and segments
GENBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$9.84−0.65 (-6.20%)
Close on Nov 17, 2026Market cap $1.26BP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Generate Biomedicines's business
Coming soon
This tab will track the numbers specific to Generate Biomedicines's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?